Formula Image (Image 1)
Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 0591-4385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 0591-4385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Image 2)
Fosaprepitant is a sterile lyophilized powder for intravenous use in single-dose vial packaging containing 150mg/vial. It is used to treat chemotherapy-induced nausea and vomiting. It should be stored in room temperature and reconstituted with sterile water or other compatible solutions. The entire contents should be withdrawn from the vial and diluted before use. Unused portions should be discarded and the single-dose vial packaging has serialization coding area to track its usage. The given text also contains product code and identification number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
